Mass Tort Research

Talcum Powder Settlements: The $8.9 Billion J&J Deal

Johnson & Johnson’s talcum powder litigation is one of the largest mass torts in U.S. history. Here is what the data shows about settlement amounts, timelines, and what claimants can expect.

$8.9B

Total Settlement Fund

J&J proposed resolution (2025)

~100,000

Pending Claims

Ovarian cancer + mesothelioma

$50K–$1M+

Expected Per-Claimant Range

Based on injury tier and diagnosis

30+ years

Litigation Timeline

First cases filed in the 1990s

Background: Why Talcum Powder Lawsuits Exist

Thousands of lawsuits allege that Johnson & Johnson’s talc-based products, including Baby Powder and Shower to Shower, were contaminated with asbestos and caused ovarian cancer and mesothelioma. The litigation gained momentum after internal J&J documents surfaced in 2018 showing the company had known about potential asbestos contamination for decades.

J&J discontinued talc-based Baby Powder in North America in 2020 and globally in 2023, switching to a cornstarch-based formula. The company has consistently denied that its talc products caused cancer, but the weight of litigation forced a resolution strategy.

The multidistrict litigation (MDL) is consolidated in the U.S. District Court for the District of New Jersey as In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL No. 2738).

Key Timeline

2018

Reuters investigation reveals J&J knew about asbestos in talc for decades. Lawsuit filings surge nationwide.

2018

A St. Louis jury awards $4.69 billion to 22 women who alleged talc caused ovarian cancer — one of the largest product liability verdicts in U.S. history (later reduced to $2.12B on appeal).

2020

J&J discontinues talc-based Baby Powder in the U.S. and Canada.

2021

J&J creates a subsidiary (LTL Management) and places it in bankruptcy via the "Texas Two-Step" strategy to resolve talc claims. Courts later reject this approach.

2023

J&J discontinues talc-based Baby Powder globally, switching entirely to cornstarch.

2024

After two failed bankruptcy attempts, J&J proposes an $8.9 billion settlement fund to resolve approximately 100,000 current and future talc claims over 25 years.

2025

Settlement plan requires 75% claimant approval to proceed. Voting and claims processing underway.

Expected Payout Ranges

The $8.9 billion settlement fund is structured in tiers based on the type of diagnosis and level of exposure evidence. While exact per-claimant amounts depend on individual case factors, the general framework follows this pattern:

Injury Tier	Estimated Range	Notes
Mesothelioma (confirmed)	$200K–$1M+	Highest tier — strong causal link to asbestos in talc
Ovarian cancer (death)	$100K–$500K	Fatal cases with documented talc use history
Ovarian cancer (survivor)	$50K–$250K	Diagnosis with evidence of long-term talc use
Other cancers	$25K–$100K	Less established causal link; case-by-case review

Note: These ranges are estimates based on publicly reported settlement structures and prior jury verdicts. Actual payouts will depend on the final claims process.

Notable Jury Verdicts

Before the global settlement proposal, several individual trials produced significant jury verdicts that shaped the litigation landscape:

$4.69 billion (2018, St. Louis) — 22 plaintiffs alleging ovarian cancer. Later reduced to $2.12 billion on appeal. The largest talc verdict to date.
$750 million (2023, New Jersey) — Awarded to a man diagnosed with mesothelioma after childhood exposure to J&J Baby Powder. Later reduced to $185 million.
$117 million (2018, California) — Awarded to a woman diagnosed with mesothelioma after decades of using J&J talc products.
$72 million (2016, St. Louis) — First major verdict in the talc litigation, awarded to the family of a woman who died of ovarian cancer.

These verdicts are significantly larger than expected individual payouts under the settlement program. However, they are the exception — many cases that went to trial resulted in defense verdicts for J&J.

Current Status & What Claimants Should Know

As of early 2026, the $8.9 billion settlement is in the approval and claims-processing phase. Key considerations for current and potential claimants:

Voting threshold: The settlement requires approval by at least 75% of current claimants to proceed.
Opt-out rights: Claimants who reject the settlement retain the right to pursue individual lawsuits, though J&J has indicated it may seek further bankruptcy proceedings.
Payment timeline: The $8.9 billion is structured to be paid out over 25 years, meaning individual payments may take years to distribute.
Statute of limitations: New claims may still be filed in some jurisdictions, but filing deadlines vary by state.

Explore More Settlement Research

See how talcum powder settlements compare to other major mass tort litigations and use our calculators to estimate settlement values.

Roundup Settlements NPDB Malpractice Study Estimate Your Settlement

Mass Tort Research

Talcum Powder Settlements: The $8.9 Billion J&J Deal

Johnson & Johnson’s talcum powder litigation is one of the largest mass torts in U.S. history. Here is what the data shows about settlement amounts, timelines, and what claimants can expect.

$8.9B

Total Settlement Fund

J&J proposed resolution (2025)

~100,000

Pending Claims

Ovarian cancer + mesothelioma

$50K–$1M+

Expected Per-Claimant Range

Based on injury tier and diagnosis

30+ years

Litigation Timeline

First cases filed in the 1990s

Background: Why Talcum Powder Lawsuits Exist

Key Timeline

2018

Reuters investigation reveals J&J knew about asbestos in talc for decades. Lawsuit filings surge nationwide.

2018

A St. Louis jury awards $4.69 billion to 22 women who alleged talc caused ovarian cancer — one of the largest product liability verdicts in U.S. history (later reduced to $2.12B on appeal).

2020

J&J discontinues talc-based Baby Powder in the U.S. and Canada.

2021

J&J creates a subsidiary (LTL Management) and places it in bankruptcy via the "Texas Two-Step" strategy to resolve talc claims. Courts later reject this approach.

2023

J&J discontinues talc-based Baby Powder globally, switching entirely to cornstarch.

2024

After two failed bankruptcy attempts, J&J proposes an $8.9 billion settlement fund to resolve approximately 100,000 current and future talc claims over 25 years.

2025

Settlement plan requires 75% claimant approval to proceed. Voting and claims processing underway.

Expected Payout Ranges

Injury Tier	Estimated Range	Notes
Mesothelioma (confirmed)	$200K–$1M+	Highest tier — strong causal link to asbestos in talc
Ovarian cancer (death)	$100K–$500K	Fatal cases with documented talc use history
Ovarian cancer (survivor)	$50K–$250K	Diagnosis with evidence of long-term talc use
Other cancers	$25K–$100K	Less established causal link; case-by-case review

Note: These ranges are estimates based on publicly reported settlement structures and prior jury verdicts. Actual payouts will depend on the final claims process.

Notable Jury Verdicts

Before the global settlement proposal, several individual trials produced significant jury verdicts that shaped the litigation landscape:

$4.69 billion (2018, St. Louis) — 22 plaintiffs alleging ovarian cancer. Later reduced to $2.12 billion on appeal. The largest talc verdict to date.
$750 million (2023, New Jersey) — Awarded to a man diagnosed with mesothelioma after childhood exposure to J&J Baby Powder. Later reduced to $185 million.
$117 million (2018, California) — Awarded to a woman diagnosed with mesothelioma after decades of using J&J talc products.
$72 million (2016, St. Louis) — First major verdict in the talc litigation, awarded to the family of a woman who died of ovarian cancer.

Current Status & What Claimants Should Know

As of early 2026, the $8.9 billion settlement is in the approval and claims-processing phase. Key considerations for current and potential claimants:

Voting threshold: The settlement requires approval by at least 75% of current claimants to proceed.
Opt-out rights: Claimants who reject the settlement retain the right to pursue individual lawsuits, though J&J has indicated it may seek further bankruptcy proceedings.
Payment timeline: The $8.9 billion is structured to be paid out over 25 years, meaning individual payments may take years to distribute.
Statute of limitations: New claims may still be filed in some jurisdictions, but filing deadlines vary by state.

Explore More Settlement Research

See how talcum powder settlements compare to other major mass tort litigations and use our calculators to estimate settlement values.

Roundup Settlements NPDB Malpractice Study Estimate Your Settlement